1887

oa Southern African Journal of Epidemiology and Infection - Re-evaluating the role of piperacillin-tazobactam in the treatment of hospital-acquired infections : original research

Volume 28, Issue 1
  • ISSN : 1015-8782
  • E-ISSN: 2220-1084

 

Abstract

The objectives were to determine the minimum inhibitory concentrations (MICs) of piperacillin-tazobactam against blood culture isolates over a two-year period, and to compare the MICs with isolates from the same site upon the South African launch of piperacillin-tazobactam. The intention was to to use the MIC data to evaluate and contextualise contemporary dosing strategies of piperacillin-tazobactam in South Africa. MICs were determined using broth microdilution antimicrobial susceptibility testing. A comparison of susceptibility between the two time periods was carried out using Fisher's exact test. The MIC data were then used to evaluate current dosing strategies based on current evidence-based pharmacodynamic parameters for piperacillin-tazobactam. A significant decrease in susceptibility was observed for (p-value = 0.0009), spp. (p-value = 0.0001), spp. (p-value = 0.0001) and (p-value = 0.0388) with MIC ≥ 128. spp., and spp./ spp. demonstrating reduced susceptibility (combined intermediate and resistant) of 44%, 11%, 20% and 0%, respectively. No significant difference in susceptibility between current extended spectrum beta-lactamase (ESBL)- and non-ESBL-producing isolates was seen with a lower MIC for ESBL-producing spp. and spp., compared to their non-ESBL-producing counterparts. The MIC data suggest that more targeted dosing strategies that aim to optimise pharmacodynamic parameters are needed. Piperacillin-tazobactam remains a valuable antimicrobial agent whose continued longevity will depend on appropriate optimisation of pharmacodynamic parameters. This requires the application of MIC-based susceptibility data to clinical use, with local assessment of the applicability of various dosing strategies that is based on cumulative antimicrobial susceptibility data.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/mp_sajei/28/1/EJC136682
2013-01-01
2017-10-23

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error